Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Effect of Alisma plantago-aquatica Linn extract on chronic prostatitis in rats

Xiao-ming Wang, Dong-dong Wang, Yu-zheng Wu, Peng-de Ma, Guang Sun, Yong Xu

Department of Urology, Tianjin second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin 300211, China;

For correspondence:-  Yong Xu   Email: xuyong494@sina.com   Tel:+8613001309410

Received: 24 July 2016        Accepted: 10 April 2017        Published: 30 May 2017

Citation: Wang X, Wang D, Wu Y, Ma P, Sun G, Xu Y. Effect of Alisma plantago-aquatica Linn extract on chronic prostatitis in rats. Trop J Pharm Res 2017; 16(5):1091-1095 doi: 10.4314/tjpr.v16i5.17

© 2017 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To study the effect of Alisma plantago-aquatica Linn. extract (APLE) on chronic prostatitis in rats.
Methods: Experimental chronic non-bacterial prostatitis (CNP) was induced in rats by injecting carrageenan into prostate. Rats in drug-treated groups were administered APLE or cernilton (positive control, i.e., reference standard) for 3 weeks while rats in normal and negative control groups were treated with saline at the same time. After treatment, prostate index (PI) and prostate-specific antigen (PSA) of all the rats were examined by enzyme-linked immunosorbent assay (ELISA). In addition, the relative inflammatory factors, tumor necrosis factor-α (TNF-α), interleukin 1β (IL-1β), cyclooxygenase-2 (COX-2), prostaglandin E2 (PEG2), transforming growth factor-β1 (TGF-β1) and connective tissue growth factor (CTGF) of the prostate tissues were measured by ELISA.
Results: A high dose of APLE (480 mg/kg) significantly decreased PI (0.7 ± 0.2 mg/g) relative to reference group (2.8 ± 0.3 mg/g, p < 0.01), and significantly decreased PSA level (128.6 ± 12.3 pg/mL) relative to reference group (321.3 ± 16.4 pg/mL, p < 0.01). Compared with reference group, TNF-α level (109.7 ± 9.3 pg/mL, p < 0.01), IL-1β level (98.3 ± 12.5 pg/mL, p < 0.01), PEG2 level (81.5 ± 4.2 pg/mL, p < 0.01), COX-2 level (10.5 ± 2.6 pg/mL, p < 0.01), TGF-β1 level (86.8 ± 7.3 pg/mL, p < 0.01) and CTGF level (70.3 ± 4.3 pg/mL, p < 0.01) of prostate tissues of high-dose APLE group rats decreased significantly.
Conclusion: APLE shows significant anti-chronic prostatitis activity in rats. Further studies are, however, required to ascertain its therapeutic potentials in humans

Keywords: Alisma plantago-aquatica, Chronic prostatitis, Inflammation, Prostate index, Morphometric analysis, Interstitial fibrosis

Impact Factor
Thompson Reuters (ISI): 0.523 (2021)
H-5 index (Google Scholar): 39 (2021)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2024; 23: 
1,   2,   3,   4
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2013; 12: 
1,   2,   3,   4,   5,   6
2012; 11: 
1,   2,   3,   4,   5,   6
2011; 10: 
1,   2,   3,   4,   5,   6
2010; 9: 
1,   2,   3,   4,   5,   6
2009; 8: 
1,   2,   3,   4,   5,   6
2008; 7: 
1,   2,   3,   4
2007; 6: 
1,   2,   3,   4
2006; 5: 
1,   2
2005; 4: 
1,   2
2004; 3: 
1
2003; 2: 
1,   2
2002; 1: 
1,   2

News Updates